Search clinical trials for: paricalcitol injection 4 mcg/mL

Total 858 results

Abbott
Massachusetts General Hospital; Harvard University

Terminated

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 (PRIMO II)

Hypertrophy, Left Ventricular | Chronic Kidney Disease (CKD) Stage 5

Italy, United States, Taiwan, Poland, United Kingdom, Greece, Germany, Russian Federation, Spain, Australia, Czech Republic, Puerto Rico, Romania
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions

Healthy

India
Ampio Pharmaceuticals. Inc.

Completed

An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

Osteoarthritis of the Knee
Ampio Pharmaceuticals. Inc.

Completed

A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain

Osteoarthritis of the Knee

United States
Ampio Pharmaceuticals. Inc.

Completed

A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee

Osteoarthritis of the Knee

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe